Food&Fertility: Food Intake Among Women and Men in Fertility Treatment

Sponsor
Aalborg University Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05454046
Collaborator
Statens Serum Institut (Other), Herlev and Gentofte Hospital (Other), Skive Regional Hospital (Other), Horsens Regional Hospital (Other)
4,000
4
36
1000
27.8

Study Details

Study Description

Brief Summary

Worldwide infertility is highly prevalent and lifestyle factors, such as food intake, could have an essential role in the success of a fertility treatment. The literature is not consistent and adequate for recommendations to the increasing number of women and men of reproductive age who ask for lifestyle guidance. Therefore, the aims of the Food & Fertility study will be to investigate the association between food intake and semen quality, pregnancy- and live birth rates in women and men undergoing assisted reproductive technology (ART) treatment.

Condition or Disease Intervention/Treatment Phase
  • Other: Food intake among women and men in fertility treatment

Detailed Description

The Food & Fertility study is a multicenter prospective cohort study which is planned to enroll a total of 4000 women and men between 2022 and 2024. The data collection will take place in four fertility clinics through a web-based food frequency questionnaire (FFQ). Data on sperm quality and pregnancy- and live birth rates will be obtained from medical records and national registers.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
4000 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Food & Fertility - Does Food Intake Affect Your Fertility?
Anticipated Study Start Date :
Aug 1, 2022
Anticipated Primary Completion Date :
Aug 1, 2025
Anticipated Study Completion Date :
Aug 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Women

Other: Food intake among women and men in fertility treatment
Filling in an FFQ

Men

Other: Food intake among women and men in fertility treatment
Filling in an FFQ

Outcome Measures

Primary Outcome Measures

  1. Probability of live birth [From filling out the FFQ to birth (approximately 9-10months)]

  2. Probability of pregnancy [From filling out the FFQ to end of treatment cycle (approximately 3 weeks)]

  3. Semen quality [+/- 3 months from filling out the FFQ]

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Women and men undergoing fertility treatment: in vitro fertilization (IVF), intracytoplasmatic sperm injection (ICSI), frozen-thawed embryo transfer (FET) or intrauterine insemination (IUI).

  • Availability of a semen sample analyzed 3 months before or after filling in the FFQ.

  • Read and understands Danish.

Exclusion Criteria:
  • Treatment with double donation (both semen and oocyte donation)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Aalborg University Hospital Aalborg Denmark
2 Herlev Hospital Copenhagen Herlev Denmark
3 Regional Hospital Horsens Horsens Denmark
4 Regional Hospital Skive Skive Denmark

Sponsors and Collaborators

  • Aalborg University Hospital
  • Statens Serum Institut
  • Herlev and Gentofte Hospital
  • Skive Regional Hospital
  • Horsens Regional Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ulrik Schiøler Kesmodel, Professor, Aalborg University Hospital
ClinicalTrials.gov Identifier:
NCT05454046
Other Study ID Numbers:
  • AGR-2019-731-9666
First Posted:
Jul 12, 2022
Last Update Posted:
Aug 5, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ulrik Schiøler Kesmodel, Professor, Aalborg University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 5, 2022